Clinical Trials Sponsored by Maxygen ApS

Total 1189 results

Alberta Health services

Completed

Pharmacist Discharge Medication Reconciliation Study

Medication Reconciliation

Canada
AlgiPharma AS
Eurostars; Smerud Medical Research International AS

Completed

A Phase IIb Study of OligoG in Subjects With Cystic Fibrosis (SMR-2984)

Cystic Fibrosis

United Kingdom, Denmark, Norway, Germany, Sweden
PCI Biotech AS

Terminated

PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer (RELEASE)

Cholangiocarcinoma

United States, Spain, Belgium, Germany, Italy, Denmark, Finland, France, Korea, Republic of, Norway, Poland, Sweden, Taiwan, Ukraine
SoftOx Solutions AS

Completed

Safety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg Wounds

Venous Leg Ulcer | Chronic Leg Ulcer

Denmark
SoftOx Solutions AS

Completed

Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects

Healthy Volunteers | Safety

Denmark
PCI Biotech AS

Completed

A Phase I/II Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

Cholangiocarcinoma

Germany, France, Norway, United Kingdom
PCI Biotech AS

Completed

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Healthy Volunteer

United Kingdom
PCI Biotech AS

Completed

Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Cancer

Head and Neck Neoplasms | Skin Neoplasms

United Kingdom
SoftOx Solutions AS

Unknown

Safety and Performance of SoftOx Wound Irrigation Solution (SWIS) in Acute Wounds (SWIS-01)

Acute Wounds

Denmark
Olympic Seafood AS

Completed

Safety and Tolerability of Krill Powder Supplement in Slightly Overweight People With Moderately Elevated Blood Pressure

Adverse Drug Event | Side Effects of Drugs

Finland
Lytix Biopharma AS

Completed

A Phase I/IIa Study to Evaluate the Safety, Tolerability and Efficacy of Topical LTX-109 in Subjects Nasally Colonized With Methicillin-resistant/-Sensitive Staphylococcus Aureus (MRSA/MSSA)

Nasal Carriers MRSA

Sweden
Mekos Laboratories AS

Completed

Clinical Evaluation of Bacitracin

Allergic Contact Dermatitis

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Johns Hopkins University; Axogen Corporation

Completed

Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy

Cancer | Neuropathy | Malignant Neoplasm | Chemotherapy-induced Peripheral Neuropathy | Malignancy | Neuropathies Sensory

United States
Mode Sensors AS

Recruiting

Assessing Hydration Status With a Wearable Bioimpedance Sensor in Elderly Individuals (HELD)

Dehydration

Norway
Chemi-Pharm AS

Recruiting

The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals

SARS CoV 2 Infection

Estonia
PCI Biotech AS

Terminated

A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Recurrent Head and Neck Cancer | Carcinoma, Squamous Cell of Head and Neck

Germany, United Kingdom, France, Lithuania, Netherlands, Poland
SoftOx Solutions AS

Completed

Safety and Performance of SWIS in Superficial Wounds

Wound of Skin

Denmark
Bionor Immuno AS

Completed

Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV

HIV I Infection

Germany, United States, Spain, United Kingdom, Italy
Bionor Immuno AS

Completed

Immunotherapy With Vacc-C5 With Adjuvant GM-CSF or Alhydrogel in HIV-1-infected Subjects on ART

HIV-1 Infection

Norway
Revmatismesykehuset AS
Abbott

Completed

Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment (PSARA)

Rheumatoid Arthritis | Endothelial Dysfunction | Psoriatic Arthritis | Ankylosing Spondylitis | Inflammatory Disease Activity

Norway
Eurodiet Scandinavia AS

Completed

The Effect of the Treatment Program "Dr. Fedon Lindbergs Vektcoach" on Body Weight and Composition and Hormonal Profile

Obesity | Overweight | Metabolic Syndrome

Norway
Mekos Laboratories AS

Unknown

Quaternium-15, Use Test

Allergic Contact Dermatitis Towards Quaternium-15

Denmark
Mekos Laboratories AS

Completed

Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate

Allergic Contact Dermatitis

Denmark
Adela Drozdova

Not yet recruiting

Use of VR in Patients' Education Prior to Implantation of PPM

Pacemaker DDD
Adela Drozdova

Not yet recruiting

VR Education in Patients Undergoing Coronary Angiography

Coronary Arteriosclerosis
Milton S. Hershey Medical Center
ALS Association

Recruiting

Remote Pulmonary Function Testing and Nurse Coaching in ALS

ALS

United States
AHS Cancer Control Alberta
Ozmosis Research Inc.

Completed

Rosuvastatin in the Treatment of Rectal Cancer

Rectal Cancer

Canada
Sykehuset Telemark
Helse Sor-Ost; ALS Norge

Enrolling by invitation

Genetic Study of Amyotrophic Lateral Sclerosis in Norway (GAIN)

Amyotrophic Lateral Sclerosis

Norway
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients

Metastatic Solid Malignancies | Locally Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer Subjects (LYNC)

Breast Cancer | Lymphedema

Canada
AHS Cancer Control Alberta
University of Calgary

Completed

The Breast Cancer & Physical Activity Level (BC-PAL) Pilot Study (BC-PAL)

Breast Cancer Survivorship

Canada
University of Calgary
Brain Canada; ALS Canada

Unknown

A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS) (Pimozide2)

Amyotrophic Lateral Sclerosis | ALS

Canada
AHS Cancer Control Alberta
Alberta Cancer Foundation

Unknown

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma (NivoPlus)

SCCHN

Canada
AHS Cancer Control Alberta
Hoffmann-La Roche

Completed

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma (PET-Chop)

Diffuse Large B Cell Lymphoma

Canada
AHS Cancer Control Alberta
Calgary Health Region

Completed

Sublingual Methadone for the Management of Cancer Breakthrough Pain

Pain | Cancer
AHS Cancer Control Alberta
Calgary Health Region

Unknown

The Utility of FDG-PET for Radiation Treatment in NSCLC

Lung Neoplasms | Positron Emission Tomography

Canada
ANS Pharma
Allergisa Pesquisa Dermato-Cosmetica LTDA

Unknown

Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer (Apotech)

Skin Care | Skin Diseases, Metabolic

Brazil
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Metabolism of Lipids in Advanced Cancer

Lung Neoplasms | Cachexia

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

The Feasibility of Physical Activity in Advanced Cancer Patients

Advanced Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer

Lung Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms | Thyroid Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Development of Magnetic Resonance (MR) Simulation for Treatment Planning

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Optimization of Spectroscopic Imaging Parameters and Procedures for Prostate at 3 Tesla Using an External Probe

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Self-Gated Breath-Hold Technique for Helical Tomotherapy in Patients With Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy

Head and Neck Cancer
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma

-Breast Neoplasms

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

Frequency of Portal Images Required to Enhance Quality Assurance for Breast Cancer Patients Treated With Radiotherapy

Breast Cancer
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Quantifying Lung Tumor Movement Under Deep Inspiration Breath Holds

Lung Cancer

Canada
University of Alberta

Unknown

Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research (MANTICORE)

Heart Failure | Breast Cancer

Canada

Clinical Trials Sponsored by Maxygen ApS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations